Search Results 1301-1310 of 18865 for Fungus
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration; Chronic obstructive pulmonary disease exacerbation or ...
Treatment for any serious bacterial, viral, parasitic, or systemic fungal infections within the 30 days prior to study entry. Positive test for HIV or ...
Oral or vaginal candidiasis and cutaneous or nail fungal infections do not constitute an exclusion. Any of the following within 12 weeks prior to Day 1 ...
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration;; Chronic obstructive pulmonary disease exacerbation or ...
Subject has a potentially serious acute or chronic infection or immunodeficiency condition, including tuberculosis, fungal, bacterial, viral/parasite ...
Evidence of serious active viral, bacterial, or uncontrolled systemic fungal infection;; Active autoimmune disease or a history of autoimmune disease within ...
Subject has known unresolved lower respiratory tract infection (e.g., pneumonia, mycobacterium avium-intracellulare infection (MAI), fungus, tuberculosis).
Uncontrolled or active systemic fungal, bacterial, viral or other infection despite appropriate anti-infective treatment at the time of leukapheresis, or ...
Active viral, bacterial, or systemic fungal infection requiring parenteral treatment within 7 days of first study drug administration; Known history of ...
Suspected or diagnosed allergic fungal rhinosinusitis. Suspected or diagnosed cystic fibrosis. Dupixent coverage denied through insurance or Dupixent MyWay ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.